Adenovirus type 35 (Ad35) is a group B adenovirus that has been isolated primarily from patients with acquired immunodeficiency syndrome and other immunodeficiency disorders. We have studied the interaction of this unique adenovirus with the immune system by analyzing Ad35 early viral proteins in infected HeLa cells. We have identified a 29,000-Mr Ad35 early glycoprotein, E29, which associates with class I antigens of the major histocompatibility complex (MHC) in the endoplasmic reticulum. Ad35 E29 is analogous to the group C Ad2 early glycoprotein E3-19K (E19), which has been shown to interfere with the expression of class I antigens on the cell surface (H. Burgert and S. Kvist, Cell 41:987-997, 1985). In contrast to the Ad2 glycoprotein, Ad35 E29 was synthesized in much smaller amounts, was more extensively glycosylated, and did not cross-react with polyclonal antibody against the Ad2 protein. As a control, a class I antigen-binding glycoprotein from another group B adenovirus, Ad7, was also characterized and was found to have properties similar to those of Ad35 E29. Therefore, the differences in the glycosylation and quantity of class I antigen-binding glycoproteins between Ad35 and Ad2 are group related. Inhibition of the expression of MHC class I antigens, which are needed for cytotoxic-T-lymphocyte recognition of virus-infected cells, appears to play a vital role in the adenovirus life cycle in vivo. Our data indicate that this function has been conserved despite significant differences in the MHC class I antigen-binding glycoprotein and in the pathogenicity between serotypes.
Adenoviruses are lytic DNA viruses which cause a variety of acute diseases, including respiratory, gastrointestinal, urinary, and ophthalmologic infections (12) . There are 41 known human serotypes, which have been subdivided into seven groups (A to G) based on hemagglutination patterns, oncogenicity in rodents, and DNA homology (27) . In addition to acute pathology, adenoviruses are persistently shed in feces for years postinfection in normal individuals (7) . Adenoviruses can also exist in a latent state and cause disseminated disease in immunocompromised patients due to reactivation (22, 28) . The mechanism(s) by which adenoviruses establish persistent and latent infections is unknown.
We have been studying adenovirus type 35 (Ad35) and the closely related Ad34, which are group B adenoviruses that have been isolated primarily from immunocompromised hosts (11, 24) . We have reported previously that over 10% of patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex examined at our institution had urine cultures positive for Ad35, though it was not isolated from other body sites (13) . Most of the patients in our survey remained free of symptoms characteristically attributed to adenovirus infections despite persistent Ad35 viruria and did not produce specific antibody to Ad35 (6) . It is unclear whether the frequent isolation of Ad35 in AIDS patients is due to reactivation or represents primary infection. Presumably, Ad35 can remain latent in the kidney, as reflected by the transmission of Ad35 infection via renal transplantation, but this is an unusual event. Ad35 infection appears to be uncommon in the general population because this serotype was rarely isolated during our survey of normal individuals with febrile illnesses and because Ad35-specific antibody was present at a very low titer in pooled immunoglobulin.
We have proposed that Ad35 may be unique from other adenoviruses in its interaction with the immune system. Unfortunately, there is no well-established animal model using human adenovirus strains that can be used to study this hypothesis. However, intriguing in vitro studies have implicated several adenovirus early proteins as modulators of the immune response, specifically via interference with the expression of major histocompatibility complex (MHC) class I antigens. In cells transformed by Adl2 (group A), a serotype which is highly oncogenic in rodents, the adenovirus early region ElA has been shown to specifically inhibit the posttranscriptional processing of class I mRNA (26) . In contrast, in the group C Ad2-infected cells and in cells transfected with the Ad2 early region 3 (E3), the E3-19K glycoprotein binds to class I antigens in the endoplasmic reticulum (1, 3) . This protein-protein interaction inhibits the normal processing and transport of the MHC antigens, thereby reducing expression on the cell surface. Since class I antigens are necessary for cytotoxic-T-lymphocyte recognition of virus-infected cells, a reduction in the level of cell surface MHC antigens may modulate acute pathogenicity (4 were also included in the study as controls. As described above, cells were infected with each purified virus at a high multiplicity of infection in order to produce a synchronized early infection. Cycloheximide (25 jig/ml) was added at 2 h postinfection to enhance the relative abundance of early viral RNA (6) . At 5 h, the cycloheximide was removed, and the cells were labeled with [35Slmethionine for 4 h in the presence of cytosine arabinoside (4 pg/ml) to prevent both viral DNA synthesis and the subsequent synthesis of late viral proteins. Whole-cell extracts were analyzed by SDS-PAGE (Fig. 1) . In the Ad2-infected cell lysate, polypeptides representing the early-region E2-72K (DBP). E3-19K, E1B-15K, E3-14K, and E4-11K were clearly visualized, as indicated in the figure, above the cellular protein background in the uninfected control (20) . In contrast, the viral polypeptide patterns seen in the Ad35-and Ad7-infected cell lysates differed from those of lysates infected with Ad2 but were identical to each other. The Ad35 and Ad7 60K polypeptides presumably represented DBPs, and the three smaller viral polypeptides in the 10.000-to 15,000-Mr range also appeared to be similar to the smaller early Ad2 proteins. However, no protein analogous to Ad2 E19 was specifically identified.
Ad35 produces a 29,000-Mr early glycoprotein. (8, 25) . Endo H specifically cleaves asparagine-linked (N-linked) high-mannose oligosaccharides such as Man5_9 GIcNAc2 (Man, mannose; GlcNAc, N-acetylglucosamine) between the first and second GlcNAc. In contrast. N-linked complex oligosaccharides, in which the distal mannose residues have been replaced by other sugars such as galactose and sialic acid, are resistant to endo H. As shown in Fig. 4 Immunoprecipitation of Ad35 E29. For further comparison of the Ad2 and Ad35 glycoproteins, the antigenicity was evaluated by immunoprecipitation of the [3H]mannoselabeled cell lysates. A polyclonal antiserum against purified, denatured Ad2 E19 was produced in a rabbit, as described in Materials and Methods. Cell lysates were solubilized in 1% SDS to dissociate the viral proteins, and the denatured lysates were diluted to 0.1% SDS before immunoprecipitation. This antiserum specifically precipitated the E19 glycoprotein from the Ad2-infected cell lysate (Fig. 6 ). In contrast, neither the Ad35 nor the Ad7 glycoprotein was precipitated by this Ad2 antiserum. Thus, the Ad35 and Ad7 glycoproteins do not appear to share antigenic determinants with the Ad2 glycoprotein.
As a measure of functional activity, the Ad35 29K glycoprotein was then analyzed for the ability to bind to MHC class I antigens by immunoprecipitation with a monoclonal antibody (W6/32) against HLA class I heavy-chain molecules. The 45K band (Fig. 7) Ad35 is needed in order to understand its unique association the product of the Ad7 E3 region (14) , was similar in size and with patients with AIDS and other immune disorders. quantity to Ad35 E29. The Ad7 data suggest that the differences between the Ad35 and Ad2 glycoproteins are
